Barclays PLC Ars Pharmaceuticals, Inc. Comm Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

A detailed history of Barclays PLC transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Barclays PLC holds 111,666 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111,666
Previous 111,666 -0.0%
Holding current value
$0
Previous $1.62 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
N/A
73,127 Added 189.75%
111,666 $1.62 Million
Q2 2024

Aug 14, 2024
BUY
N/A
8,666 Added 29.01%
38,539 $328,000
Q1 2024

May 15, 2024
SELL
N/A
-10,501 Reduced 26.01%
29,873 $306,000
Q4 2023

Feb 15, 2024
BUY
N/A
22,597 Added 127.11%
40,374 $222,000
Q3 2023

Nov 07, 2023
SELL
N/A
-2,683 Reduced 13.11%
17,777 $66,000
Q2 2023

Aug 03, 2023
SELL
N/A
-15,322 Reduced 42.82%
20,460 $138,000
Q1 2023

May 04, 2023
BUY
N/A
14,972 Added 71.95%
35,782 $232,000
Q4 2022

Feb 13, 2023
BUY
N/A
825 Added 4.13%
20,810 $177,000
Q3 2022

Nov 03, 2022
SELL
N/A
-912 Reduced 4.36%
19,985 $106,000
Q2 2022

Aug 12, 2022
BUY
N/A
3,792 Added 22.17%
20,897 $89,000
Q1 2022

May 16, 2022
BUY
N/A
17,105 New
17,105 $60,000

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email